Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Sandoz | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Mexico | es
United States | en
Australia | en
Japan | ja
Korea | ko
Mainland China | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Global | en
Sandoz | en
Saudi Arabia | ar
Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Sandoz

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Croatia | hr
Czech Republic | cs
Denmark | da
Finland | fi
France | fr
Germany | de
Hungary | hu
Italy | it
Japan | ja
Korea | ko
Mainland China | zh
Mexico | es
Netherlands | nl
Norway | no
Global | en
Sandoz | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Saudi Arabia | ar
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Turkey | tr
United Kingdom | en
United States | en
    • About Sandoz 
      • Our Purpose and Ambition 
      • What We Do 
      • Innovation, Quality and Supply 
      • Corporate Responsibility 
        • Ethics, Risk and Compliance 
        • Sandoz external funding 
        • Malaria Initiative 
        • Novartis Access 
        • World Child Cancer 
      • Our History 
      • Investor Information 
      A girl with a flower About Sandoz
    • Products & Services 
      • Disease Areas 
        • Anti-Infectives 
        • Respiratory 
        • Endocrinology 
        • Immunology 
        • Oncology 
      • Biopharmaceuticals 
        • Value of Biosimilars 
        • Sandoz Biosimilar Portfolio 
        • Sandoz Biosimilar Pipeline 
        • About Biologics 
        • Science of Biosimilars 
        • Information for Patients 
      • Prescription Medicines 
      • Over-The-Counter Medicines 
      • Partnerships and Collaborations 
        • Biotech Cooperations 
        • Business to Business (B2B) 
      00181_300dpi_RGB Products & Services
    • People & Culture 
      • Board of Directors 
      • Sandoz Leadership 
        • Richard Saynor 
        • Francisco Ballester 
        • Martin Bischof 
        • Colin Bond 
        • Pierre Bourdage 
        • Valerie Chew 
        • Claire D'Abreu-Hayling 
        • Glenn A. Gerecke, PhD 
        • Rebecca Guntern 
        • Keren Haruvi 
        • Tripti Jha 
        • Steffen Kurzawa 
        • Ingrid Sollerer 
      • Diversity & Inclusion 
      • Associate Stories 
    • Investors & Media 
      • Sandoz spin-off 
      • Media Releases 
      • Media Library 
      • Media Contacts 
      • Novartis Annual Reporting Suite 
    • Careers 
      • Working at Sandoz 
      • Diversity & Inclusion 
      • Associate Stories 
      • Job Search 
      • Our Teams 
        • Sandoz Technology 
        • Sandoz People & Organization 
      • Personal Growth & Learning at Sandoz 
      Sandoz Careers Careers
    • News 
      • News Archive 
      • Media Releases 
      • Publications 
      • Stay Up-To-Date 
      A photo of people in a meeting hall News
    • Contacts 
    working at sandoz Home
Header
A photo of people in a meeting hall

News

News and more from the frontiers of medicine

Previous Next

Latest News

Jun 01, 2023

Sandoz plans move to new central Basel headquarters by mid-2024, following proposed spin-off as standalone company

May 25, 2023

Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA

May 15, 2023

New Sandoz Board of Directors appointed

View More
image016

All News

Read in-depth news about how Sandoz is addressing healthcare needs through recent headlines.

lung-cancer-hero-image

Media Releases

Find announcements about Sandoz products, programs and company updates.

Publications

Read, download and order key company publications including annual and performance reports.

Stay Up-To-Date

Subscribe to the latest news and updates from Novartis on email, RSS and more.

Quick links

Who We Are
What We Do
Corporate Responsibility
Working at Sandoz
site-directory

Site Directory

Sandoz today has a strong presence on all continents and is well represented in all key generics markets, allowing us to remain close to patients, doctors, healthcare providers and business partners everywhere.

Explore

Sandoz Global

Key resources
  • Patients & Caregivers
  • Job seekers
  • Investors
  • Media
Recent updates
  • Sandoz spin-off
Explore
  • Contacts
  • Locations
  • Biosimilar Portfolio and Pipeline
Sandoz Companies
  • 1A Pharma
  • Hexal
  • Lek
Footer Bottom
© 2023 Sandoz International GmbH
  • Terms of Use
  • Privacy Policy
  • About Cookies
  • Legal Notice
  • Social Media Community Guidelines
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience